Eucrates Biomedical Acquisition Corp.
| IPO Proceeds, $M | $104.80M |
|---|---|
| IPO Date | Oct 23, 2020 |
| CEO | Parag Saxena |
| Left Lead | Stifel Nicolaus |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 + 6 |
| IPO Sector |
Healthcare
Healthcare in North America and Europe |
| IPO Geography | US/Canada |
| Target Company | N/A |
| Deal Announced | N/A |
| Deal Size, $M | TBD |
| Deal Sector | TBD |
| Deal Geography | TBD |
| SEC Filings | www.sec.gov |
| Approval Vote | TBD |
| Amendment Vote | Oct 24, 2022 |
| Closing Date | Apr 26, 2023 |
| Price | |
|---|---|
| Volume, 3-month avg. | N/A |
No credit card required
Sign in for more on Eucrates Biomedical Acquisition Corp.:
- Structure and cap table
- 10 directors & officers
- 12 filings and events
- 2 underwriters
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Dr. Stelios Papadopoulos | 72 | Chairman |
| Parag Saxena | 65 | CEO and Director |
| Dr. Evangelos (Vangelis) Vergetis | 40 | President, COO and Director |
| Gonzalo Cordova | 65 | CFO |
| Shrikant Sathe | 65 | Senior VP |
| Atanuu Agarrwal | 31 | VP |
| Daphne Karydas | 47 | Director |
| William Campbell | 76 | Director |
| Nina Shapiro | 72 | Director |
| Amitabh (Amit) Singhal | 52 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
| Stifel Nicolaus | Joint BR | 7,000,000 | units |
| H.C. Wainwright | Joint BR | 3,000,000 | |
| 10,000,000 | units | ||
| Up-Front UW fee | 2.00 | % | |
| Deferred UW fee |
3.50 | % |
Sign in to view more advisor data.
Filings
| Oct 6, 2020 | Initial S-1 |
| Oct 15, 2020 |
S-1/A Amendment #1
Sign In to view filing content. |
| Oct 21, 2020 |
S-1/A Amendment #2
Sign In to view filing content. |
| Oct 23, 2020 |
PR announcing pricing of $100mm IPO
Sign In to view filing content. |
| Oct 26, 2020 | 424B4 IPO Prospectus |
| Nov 30, 2020 |
8-K announcing partial over-allotment exercise
Sign In to view filing content. |
| Dec 14, 2020 |
8-K announcing separate trading of common stock and warrants
Sign In to view filing content. |
| Sep 28, 2022 |
PRE14A Preliminary proxy for charter extension meeting
Sign In to view filing content. |
| Oct 5, 2022 |
PRER14A revised preliminary proxy for charter extension meeting
Sign In to view filing content. |
| Oct 12, 2022 |
DEF14A Definitive proxy for charter extension meeting
Sign In to view filing content. |
| Oct 24, 2022 |
8-K with extension meeting results
Sign In to view filing content. |
| Apr 11, 2023 |
8-K announcing liquidation and redemption of all public shares
Sign In to view filing content. |